Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Schmidt

Showing results (171-180 of 344) with videos related to

Pageof 35
Sort By:
Geburtshilfe Und Frauenheilkunde|September 4, 2024
Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast CancerEugen Ruckhäberle, Marcus Schmidt, Anja Welt, et al.
Breast Cancer Research : BCR|March 4, 2005
Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testingMarcus Schmidt, Barbara Lewark, Nikolai Kohlschmidt, et al.
Inorganic Chemistry|October 26, 2020
Cage Adaption by High-Pressure Synthesis: The Clathrate-I Borosilicide Rb<sub>8</sub>B<sub>8</sub>Si<sub>38</sub>Julia-Maria Hübner, Walter Jung, Marcus Schmidt, et al.
Journal of Cancer Research and Clinical Oncology|April 3, 2024
Prognostic impact of metabolic syndrome in patients with primary endometrial cancer: a retrospective bicentric studyIna Shehaj, Slavomir Krajnak, Morva Tahmasbi Rad, et al.
Journal of Cancer Research and Clinical Oncology|December 8, 2025
Impact of preoperative geriatric screening and comorbidity assessment in patients with vulvar and vaginal cancerValerie Catherine Linz, Emma Liebau, Markus Schepers, et al.
Journal of Cancer Research and Clinical Oncology|September 27, 2014
Adjuvant treatment decisions for patients with endometrial cancer in Germany: results of the nationwide AGO pattern of care studies from the years 2013, 2009 and 2006Marco Johannes Battista, Marcus Schmidt, Nicole Rieks, et al.
Oncology Research|March 9, 2026
Prognostic Significance of DNA Repair Gene mRNA Expression in Early-Stage Breast Cancer: Insights into Clinical RelevanceIna Shehaj, Slavomir Krajnak, Katrin Almstedt, et al.
BMC Cancer|December 17, 2014
Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patientsIsabel Sicking, Karlien Rommens, Marco J Battista, et al.
Journal of Cancer Research and Clinical Oncology|April 22, 2022
Comparison of cisplatin and mitomycin C/5-FU as radiosensitisers in the treatment of locally advanced vulvar cancer: results of a retrospective, observational, single-institutional cohort studyValerie Catherine Linz, Carina Schwanbeck, Slavomir Krajnak, et al.
Breast Cancer Research and Treatment|May 21, 2009
Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancerThomas Karn, Dirk Metzler, Eugen Ruckhäberle, et al.
Pageof 35

Showing results (171-180 of 344) with videos related to

Sort By:
Pageof 35
Geburtshilfe Und Frauenheilkunde|September 4, 2024
Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast CancerEugen Ruckhäberle, Marcus Schmidt, Anja Welt, et al.
Breast Cancer Research : BCR|March 4, 2005
Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testingMarcus Schmidt, Barbara Lewark, Nikolai Kohlschmidt, et al.
Inorganic Chemistry|October 26, 2020
Cage Adaption by High-Pressure Synthesis: The Clathrate-I Borosilicide Rb<sub>8</sub>B<sub>8</sub>Si<sub>38</sub>Julia-Maria Hübner, Walter Jung, Marcus Schmidt, et al.
Journal of Cancer Research and Clinical Oncology|April 3, 2024
Prognostic impact of metabolic syndrome in patients with primary endometrial cancer: a retrospective bicentric studyIna Shehaj, Slavomir Krajnak, Morva Tahmasbi Rad, et al.
Journal of Cancer Research and Clinical Oncology|December 8, 2025
Impact of preoperative geriatric screening and comorbidity assessment in patients with vulvar and vaginal cancerValerie Catherine Linz, Emma Liebau, Markus Schepers, et al.
Journal of Cancer Research and Clinical Oncology|September 27, 2014
Adjuvant treatment decisions for patients with endometrial cancer in Germany: results of the nationwide AGO pattern of care studies from the years 2013, 2009 and 2006Marco Johannes Battista, Marcus Schmidt, Nicole Rieks, et al.
Oncology Research|March 9, 2026
Prognostic Significance of DNA Repair Gene mRNA Expression in Early-Stage Breast Cancer: Insights into Clinical RelevanceIna Shehaj, Slavomir Krajnak, Katrin Almstedt, et al.
BMC Cancer|December 17, 2014
Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patientsIsabel Sicking, Karlien Rommens, Marco J Battista, et al.
Journal of Cancer Research and Clinical Oncology|April 22, 2022
Comparison of cisplatin and mitomycin C/5-FU as radiosensitisers in the treatment of locally advanced vulvar cancer: results of a retrospective, observational, single-institutional cohort studyValerie Catherine Linz, Carina Schwanbeck, Slavomir Krajnak, et al.
Breast Cancer Research and Treatment|May 21, 2009
Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancerThomas Karn, Dirk Metzler, Eugen Ruckhäberle, et al.
Pageof 35